Prognostic stratification of clinically stable patients with heart failure by echocardiographic pressure/volume loop model

G Cioffi, R Battiston, C Mancusi, A Di Lenarda… - Journal of the American …, 2023 - Elsevier
Background Pressure/volume (P/V) loops provide useful information on left ventricular
performance and prognosis in patients with heart failure (HF) but do not lend themselves to …

[引用][C] Reclassifying heart failure: time for disruptive innovation?

GM Felker, T Ahmad - European Journal of Heart Failure, 2015 - Wiley Online Library
Linnaeus recognized that the correct naming and classifying of things was central to
understanding of the natural world, creating a system of taxonomy that lives on in the study …

[HTML][HTML] Biomarkers: optimizing treatment guidance in heart failure

M Böhm, AA Voors, JM Ketelslegers… - Clinical research in …, 2011 - Springer
Heart failure is a frequent and life-threatening syndrome which is not only the result of
myocardial injury or hemodynamic overload as commonly perceived, but appears to be the …

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study

E Akiyama, R Cinotti, K Čerlinskaitė… - ESC Heart …, 2020 - Wiley Online Library
Aims Changes in echocardiographic parameters and biomarkers of cardiac and venous
pressures or estimated plasma volume during hospitalization associated with decongestive …

[HTML][HTML] The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use

JL Januzzi Jr - Archives of cardiovascular diseases, 2012 - Elsevier
The care of patients with heart failure can be challenging, with few objective tools available
to assist in therapy decision-making. Natriuretic peptides are powerfully prognostic …

Clinical phenotyping of heart failure with biomarkers: current and future perspectives

V Senthong, JL Kirsop, WHW Tang - Current heart failure reports, 2017 - Springer
Introduction Heart failure (HF) is a complex clinical syndrome with diverse risk factors and
etiologies, differing underlying pathophysiology, and large phenotypic heterogeneity …

[引用][C] Heart failure with reduced ejection fraction: A review of clinical status and meta-analyses of diagnosis by 3D echocardiography and natriuretic peptides-guided …

A Albakri - Trends in Research, 2018

Characterization of hemodynamic and metabolic abnormalities in the heart failure spectrum: the role of combined cardiopulmonary and exercise echocardiography …

NR Pugliese, A Balletti, F Filidei, A Pieroni… - Minerva cardiology …, 2021 - europepmc.org
Heart failure (HF) is a complex clinical syndrome characterized by different etiologies and a
broad spectrum of cardiac structural and functional abnormalities. Current guidelines …

[引用][C] Do we need to EVALUATE multiple biomarkers and/or the same biomarkers multiple times in patients with heart failure?

A Aimo, V Castiglione… - European Journal of …, 2022 - Wiley Online Library
This article refers to 'Changes in cardiac biomarkers in association with alterations in cardiac
structure and function, and health status in heart failure with reduced ejection fraction: the …

Advances in heart failure: a review of biomarkers, emerging pharmacological therapies, durable mechanical support and telemonitoring

Y Moayedi, HJ Ross - Clinical Science, 2017 - portlandpress.com
The purpose of this review is to provide an overview of diagnosis, prognosis and
management of heart failure (HF) with reduced ejection fraction (HFrEF). Specifically, this …